Bolt Biotherapeutics, Inc. - Common Stock - Çeyreklik Bilanço (NASDAQ:BOLT) | MetaTrader

Tam grafiği aç Full chart

Haberler

Rodman & Renshaw, Bolt Biotherapeutics hissesine al önerisi verdi

Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Lags Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?

Bolt Biotherapeutics CEO’su Quinn 686 dolarlık hisse satın aldı

Nemec, Bolt Biotherapeutics Kıdemli Başkan Yardımcısı, 686 dolarlık hisse satın aldı

Bolt Biotherapeutics CEO Quinn buys shares worth $686

Nemec, Bolt Biotherapeutics SVP, acquired shares worth $686

H.C. Wainwright, Bolt Biotherapeutics hissesi için Alım tavsiyesi verdi

Bolt Biotherapeutics stock initiated with Buy rating at H.C. Wainwright

Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Mr. Cooper Gr (NASDAQ:COOP), Bolt Biotherapeutics (NASDAQ:BOLT)